AAAAAA

   
Results: 1-14 |
Results: 14
VARIATIONS OF THE COURSE OF THE INTERNAL CAROTID-ARTERY - POTENTIAL RISKS IN STANDARD OPERATIONS IN THE UPPER PHARYNX
Authors: SCHUMACHER WA SCHAFIG A KEHRL W PAU HW
Citation: Wa. Schumacher et al., VARIATIONS OF THE COURSE OF THE INTERNAL CAROTID-ARTERY - POTENTIAL RISKS IN STANDARD OPERATIONS IN THE UPPER PHARYNX, Laryngo-, Rhino-, Otologie, 77(9), 1998, pp. 517-520
A FERRET MODEL OF ELECTRICAL-INDUCTION OF ARTERIAL THROMBOSIS THAT ISSENSITIVE TO ASPIRIN
Authors: SCHUMACHER WA STEINBACHER TE MEGILL JR DURHAM SK
Citation: Wa. Schumacher et al., A FERRET MODEL OF ELECTRICAL-INDUCTION OF ARTERIAL THROMBOSIS THAT ISSENSITIVE TO ASPIRIN, Journal of pharmacological and toxicological methods, 35(1), 1996, pp. 3-10
LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN) AND THROMBIN ACTIVE-SITE INHIBITOR (ARGATROBAN) COMPARED IN EXPERIMENTAL ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING-TIME
Authors: SCHUMACHER WA HERAN CL STEINBACHER TE
Citation: Wa. Schumacher et al., LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN) AND THROMBIN ACTIVE-SITE INHIBITOR (ARGATROBAN) COMPARED IN EXPERIMENTAL ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING-TIME, Journal of cardiovascular pharmacology, 28(1), 1996, pp. 19-25
SENSITIVITY OF EXPERIMENTAL VENOUS AND ARTERIAL THROMBOSIS AND BLEEDING TO ANCROD-INDUCED DEFIBRINOGENATION
Authors: SCHUMACHER WA HERAN CL STEINBACHER TE
Citation: Wa. Schumacher et al., SENSITIVITY OF EXPERIMENTAL VENOUS AND ARTERIAL THROMBOSIS AND BLEEDING TO ANCROD-INDUCED DEFIBRINOGENATION, Thrombosis research, 81(2), 1996, pp. 187-194
DOSE-RELATED CARDIOPROTECTION BY IFETROBAN IN RELATION TO INHIBITION OF THROMBOSIS AND EX-VIVO PLATELET-FUNCTION
Authors: GOMOLL AW SCHUMACHER WA OGLETREE ML
Citation: Aw. Gomoll et al., DOSE-RELATED CARDIOPROTECTION BY IFETROBAN IN RELATION TO INHIBITION OF THROMBOSIS AND EX-VIVO PLATELET-FUNCTION, Pharmacology, 50(2), 1995, pp. 92-110
THROMBOXANE RECEPTOR ANTAGONIST BMS-180291, BUT NOT ASPIRIN, REDUCES THE SEVERITY OF PACING-INDUCED ISCHEMIA IN DOGS
Authors: GROVER GJ SCHUMACHER WA OGLETREE ML
Citation: Gj. Grover et al., THROMBOXANE RECEPTOR ANTAGONIST BMS-180291, BUT NOT ASPIRIN, REDUCES THE SEVERITY OF PACING-INDUCED ISCHEMIA IN DOGS, Journal of cardiovascular pharmacology, 24(3), 1994, pp. 493-499
2-[3-[2-(4,5-DIPHENYL-2-OXAZOLYL)ETHYL]PHENOXY] ACETIC-ACID (BMY-42393) .2. ORAL ACTIVITY AND EFFICACY IN ANIMAL-MODELS OF ARTERIAL THROMBOSIS
Authors: SEILER SM BUCHANAN JO SCHUMACHER WA ZAVOICO GB GAMBERDELLA M FLEMING JS MEANWELL NA
Citation: Sm. Seiler et al., 2-[3-[2-(4,5-DIPHENYL-2-OXAZOLYL)ETHYL]PHENOXY] ACETIC-ACID (BMY-42393) .2. ORAL ACTIVITY AND EFFICACY IN ANIMAL-MODELS OF ARTERIAL THROMBOSIS, Thrombosis research, 74(2), 1994, pp. 125-133
EFFECT OF A NOVEL THROMBIN ACTIVE-SITE INHIBITOR ON ARTERIAL AND VENOUS THROMBOSIS
Authors: SCHUMACHER WA BALASUBRAMANIAN N STLAURENT DR SEILER SM
Citation: Wa. Schumacher et al., EFFECT OF A NOVEL THROMBIN ACTIVE-SITE INHIBITOR ON ARTERIAL AND VENOUS THROMBOSIS, European journal of pharmacology, 259(2), 1994, pp. 165-171
COMPARISON OF A LOW-MOLECULAR-WEIGHT HEPARIN AND THROMBIN ACTIVE-SITEINHIBITOR IN EXPERIMENTAL ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING-TIME
Authors: SCHUMACHER WA STEINBACHER TE HERAN CL
Citation: Wa. Schumacher et al., COMPARISON OF A LOW-MOLECULAR-WEIGHT HEPARIN AND THROMBIN ACTIVE-SITEINHIBITOR IN EXPERIMENTAL ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING-TIME, Thrombosis and haemostasis, 69(6), 1993, pp. 657-657
EFFECTS OF ANTITHROMBOTIC DRUGS IN A RAT MODEL OF ASPIRIN-INSENSITIVEARTERIAL THROMBOSIS
Authors: SCHUMACHER WA STEINBACHER TE HERAN CL MEGILL JR DURHAM SK
Citation: Wa. Schumacher et al., EFFECTS OF ANTITHROMBOTIC DRUGS IN A RAT MODEL OF ASPIRIN-INSENSITIVEARTERIAL THROMBOSIS, Thrombosis and haemostasis, 69(5), 1993, pp. 509-514
COMPARISON OF A THROMBOXANE RECEPTOR ANTAGONIST AND ASPIRIN IN EXPERIMENTAL ARTERIAL THROMBOSIS
Authors: SCHUMACHER WA HERAN CL YOUSSEF S MEGILL JR MICHEL I DURHAM SK
Citation: Wa. Schumacher et al., COMPARISON OF A THROMBOXANE RECEPTOR ANTAGONIST AND ASPIRIN IN EXPERIMENTAL ARTERIAL THROMBOSIS, Haemostasis, 23(4), 1993, pp. 219-228
SUPERIOR ACTIVITY OF A THROMBOXANE RECEPTOR ANTAGONIST AS COMPARED WITH ASPIRIN IN RAT MODELS OF ARTERIAL AND VENOUS THROMBOSIS
Authors: SCHUMACHER WA HERAN CL STEINBACHER TE YOUSSEF S OGLETREE ML
Citation: Wa. Schumacher et al., SUPERIOR ACTIVITY OF A THROMBOXANE RECEPTOR ANTAGONIST AS COMPARED WITH ASPIRIN IN RAT MODELS OF ARTERIAL AND VENOUS THROMBOSIS, Journal of cardiovascular pharmacology, 22(4), 1993, pp. 526-533
COMPARISON OF THROMBIN ACTIVE-SITE AND EXOSITE INHIBITORS AND HEPARININ EXPERIMENTAL-MODELS OF ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING
Authors: SCHUMACHER WA STEINBACHER TE HERAN CL SEILER SM MICHEL IM OGLETREE ML
Citation: Wa. Schumacher et al., COMPARISON OF THROMBIN ACTIVE-SITE AND EXOSITE INHIBITORS AND HEPARININ EXPERIMENTAL-MODELS OF ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING, The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1237-1242
INTERPHENYLENE 7-OXABICYCLO[2.2.1]HEPTANE OXAZOLES - HIGHLY POTENT, SELECTIVE, AND LONG-ACTING THROMBOXANE A(2)-RECEPTOR ANTAGONISTS
Authors: MISRA RN BROWN BR SHER PM PATEL MM HALL SE HAN WC BARRISH JC KOCY O HARRIS DN GOLDENBERG HJ MICHEL IM SCHUMACHER WA WEBB ML MONSHIZADEGAN H OGLETREE ML
Citation: Rn. Misra et al., INTERPHENYLENE 7-OXABICYCLO[2.2.1]HEPTANE OXAZOLES - HIGHLY POTENT, SELECTIVE, AND LONG-ACTING THROMBOXANE A(2)-RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 36(10), 1993, pp. 1401-1417
Risultati: 1-14 |